Pharmexcil drives global pharma trade through premier healthcare export summit
NEW DELHI: iPHEX 2025 – 11th Edition of International Exhibition and Healthcare, is scheduled from September 4–6, 2025, at Bharat Mandapam, New Delhi.Organized by the Pharmexcil Pharmaceuticals Export Promotion Council of India ), with the support of Ministry of Commerce and Industry, this premier event will convene key stakeholders from the pharmaceutical industry and allied sectors. Pharmexcil, the official export promotion body under the Ministry of Commerce & Industry, represents over 4,400 Indian pharmaceutical exporters and plays a pivotal role in advancing global trade through policy advocacy, regulatory support, and market development initiatives.The event will feature dedicated International Buyers Sellers Meet, a focused exhibition with over 700 stall with a strong emphasis on research & development and innovation. It will also spotlight India's leading pharmaceutical exporters—across formulations, biosimilars, bulk drugs, and surgical—who are serving healthcare needs in over 150 countries. These capabilities will be showcased through the flagship International Exhibition on Pharmaceuticals and Healthcare (iPHEX. Since its inception in 2013, iPHEX has hosted over 5,000 foreign delegates, including regulators and buyers, and featured more than 4,000 Indian exhibitors across key cities like Mumbai, Hyderabad, New Delhi, and Ahmedabad. As a cornerstone of the Brand India Pharma campaign, the exhibition strengthens India's positioning as the 'Pharmacy of the World' by enabling focused B2B meetings, regulatory dialogues, and strategic collaborations across global markets including NAFTA, EU, ASEAN, LAC, Africa, and GCC—driving expanded market access and global confidence in Indian pharmaceutical excellence.Serving as a strategic lead-up to the 11th edition of iPHEX—India's flagship pharmaceutical export exhibition— this integrated event aims to project India's strengths in high-quality manufacturing, regulatory excellence, and global trade preparedness. Pharmexcil, which plays a pivotal role in supporting India's pharmaceutical exports (currently valued at over $30 billion annually), will facilitate B2B meetings, buyer-seller interactions, and global outreach initiatives at the venue. These efforts are intended to foster meaningful cross-border partnerships and open up new commercial avenues.Namit Joshi, Chairman of Pharmexcil, said, in a statement, 'Now in its 11th edition, iPHEX has firmly established itself as a flagship global platform that showcases India's pharmaceutical excellence. This year, the event expands its scope to include allied segments such as pharmaceutical machinery and Ayush products—broadening its relevance and impact. iPHEX has consistently created synergy and confidence among global pharma stakeholders, offering an exclusive environment for focused one-on-one business meetings, regulatory dialogues, and strategic partnerships. Our objective is to reinforce India's position as the preferred global partner for high quality, affordable pharmaceuticals.'Vice Chairman of Pharmexcil, Bhavin Mehta , said, "With participation from regulators and buyers across NAFTA, EU, Africa, ASEAN, CIS, LAC, and WANA regions, the event facilitates deep engagement through contract manufacturing discussions, technology transfers, and bilateral trade collaborations. As a niche, high-value platform, iPHEX continues to drive market access and position India as an innovation-led, reliable force in global pharma supply chains.'K Raja Bhanu, Director General, Pharmexcil, shared,' The 11th Edition of IPHEX 2025 promises to be a pivotal event for the global pharmaceutical industry. It will bring together over 25,000 domestic visitors and 700+ pharma exhibitors, with delegates from 111+ countries. The USP of Indian Generics has always been 'Quality, affordability, and scalability.' This will continue to be foundational as we move towards 'Bharath @2030 and beyond envisioning for speciality generics, biosimilars, vaccines & biologics, personalised medicines, advanced gene therapies, and CDMO/CRO services with a market size of 150 billion USD by 2030. 'The global regulatory conclave will be organized by the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare, Government of India, jointly with PHARMEXCIL, and held concurrently with iPHEX 2025. This platform will foster critical regulatory dialogues, strengthen international alignment, and enhance trust in India's regulatory ecosystem. Event will include sector-specific sessions, and panel discussions on regulatory harmonization, global market expansion strategies, innovation in manufacturing, and the evolving landscape of pharma exports.A dedicated exporters participation at the exhibition, regulatory conclave, and global buyer forum will provide unmatched opportunities for knowledge-sharing, deal-making, and policy dialogue. Designed to align with India's ambition of becoming a $65 billion pharma export powerhouse by 2030, summit embodies the spirit of 'Powering Healthcare, Connecting Markets'—bringing together industry leaders, global stakeholders & policymakers to drive meaningful collaboration, unlock new trade corridors & elevate India's role in global healthcare.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
9 minutes ago
- Business Standard
NSA Doval meets Russia's first deputy PM, discusses military-technical ties
National Security Advisor Ajit Doval held talks with Russia's First Deputy Prime Minister Denis Manturov here on bilateral military-technical ties and implementation of joint projects in strategic sectors. Doval is in Russia to hold crucial talks on bilateral energy and defence ties and to prepare the ground for President Putin's visit to India later this year. Doval and Manturov met on Friday, according to the Russian Embassy in India. The talks covered "topical issues of #RussiaIndia military-technical cooperation, as well as the implementation of joint projects in other strategic sectors, including civil aircraft manufacturing, metallurgy, and the chemical industry," the embassy said in an X post. On Thursday, Doval called on Russian President Vladimir Putin at the Kremlin to discuss bilateral cooperation between the two countries. During the meeting, he reiterated New Delhi's commitment to continue cooperation on all fronts with Russia in spite of outside pressure. The NSA's visit to Russia comes in the backdrop of US President Donald Trump slapping an additional 25 per cent tariff on Indian goods as a penalty for buying Russian oil, doubling it to 50 per cent. According to sources, Doval extended an invitation to President Putin on behalf of Prime Minister Narendra Modi to visit India later this year, which Putin has accepted with gratitude.
Business Standard
9 minutes ago
- Business Standard
Shree TMT Recognized Among Top 10 Steel Bar & Wire Manufacturers by Industry Outlook
VMPL Hyderabad (Telangana) [India], August 9: Marking a significant milestone in its journey of excellence, Shree TMT, one of South India's leading steel brands, has been featured among the Top 10 Steel Bar & Wire Manufacturers - 2025 by Industry Outlook Magazine. The recognition reinforces Shree TMT's growing leadership in the Indian steel industry through innovation, sustainability, and engineering precision. With its roots in Hyderabad, Telangana, Shree TMT has earned a strong reputation as the best steel in Hyderabad, trusted by some of the region's biggest infrastructure players. Backed by over 50 years of steelmaking legacy from the Goenka family and operated under Devashree Ispat Pvt. Ltd., Shree TMT is shaping the future of modern India, one strong foundation at a time. Shaping India's Pride, Step by Step Over the years, Shree TMT has become a preferred steel brand for top construction companies including My Home Group, Aparna Constructions, and Jayabheri Projects. The brand's commitment to high-quality TMT bars has positioned it as the go-to choice for contractors, engineers, and developers across Telangana and beyond. The company manufactures Fe550 and Fe550D grade TMT bars, known for their superior tensile strength, earthquake resistance, and long-lasting performance. These bars are ideal for complex infrastructure projects and high-rise buildings. Moreover, Shree TMT is the only manufacturer in Telangana producing 36mm diameter TMT bars as per IS 1786:2008 standards - a critical requirement for large-scale structural foundations. One of the standout innovations from Shree TMT is the 3X rib-on-rib design, which increases the bonding strength between steel and cement by over 10%. This proprietary design ensures enhanced safety, durability, and load-bearing capacity for reinforced concrete structures - a true benchmark in quality. Driving Innovation with Responsibility At the heart of Shree TMT's operations is a state-of-the-art rolling mill, powered by Swiss-backed ABB PLC systems and CNC rib-cutting technology. This automation-first approach minimizes human error and ensures consistency in every bar manufactured. In addition to performance, sustainability is a core value at Shree TMT. The company is GreenPro certified by CII, acknowledging its commitment to green steel manufacturing practices. With NABL-accredited labs, BIS certification, and a focus on in-house billet production, Shree TMT ensures full quality control from raw material to final product. In a landmark move, Shree TMT has also been approved by the Telangana State Government as an official steel supplier for all public works - a rare and prestigious achievement for any regional steel brand. The Road Ahead Looking forward, Shree TMT is investing Rs. 200 crore in setting up a captive solar power plant and sponge iron unit in Bellary, strengthening its backward integration and reducing carbon footprint. These initiatives reaffirm the company's mission to lead the industry in sustainable steel production while maintaining affordability and excellence. "Being recognized among the top steel bar manufacturers is both a validation and motivation," said Karan Goenka, Director, Shree TMT. "We are committed to delivering high-quality, innovative, and sustainable steel that builds not just structures, but a stronger India."
Time of India
9 minutes ago
- Time of India
Honda ‘working hard' to overtake Hero in Indian 2-wheeler arena
Honda Motor Company has once again reaffirmed its intent to overtake Hero MotoCorp in India's two-wheeler arena the fiscal. The Japanese automaker made this known at a recent Q&A session with analysts following its first quarter results in Japan. The transcript has been uploaded on the Honda website. 'We are working hard this term with the goal of surpassing Hero MotoCorp and becoming the best. There are some areas where we have deviated from the plan but we are on track. We will be introducing models to the market, so we will be working hard on this,' said Eiji Fujimura Director, Managing Executive Officer. Last year saw a rush of demand due to the impact of OBD2 regulatory changes, resulting in a significantly high Fujimura He added that the Q1 showing in India was weak compared to the same period last year in India. 'However, last year saw a rush of demand due to the impact of OBD2 regulatory changes, resulting in a significantly high figure.' Masao Kawaguchi Operating Executive, Head of Accounting and Finance Supervisory Unit, said that compared to last year, sales were about 180,000 units lower in India, but the operating profit margin had actually increased compared to the past and still in the double-digit ROS (return on sales) range. Vietnam, Brazil offset India drawback Vietnam and Brazil, contrast, 'have very high profit margins' which offset the decline in India. While acknowledging the risks of tariffs affecting the economies of each country in the future, 'we are confident that if India recovers steadily, countries such as Vietnam and Brazil will provide a boost, enabling us to achieve stable operating profit margins'. Will Honda finally fulfil its long-awaited desire of getting past Hero in the leadership tug-of-war? The company cannot be faulted for not trying but its former ally has still managed to stay comfortably ahead for over 15 years now even while the gap has been narrowing down in recent times. Also read:How Honda rebuilt its 2-wheeler brand in India after the Hero divorce Since the time it parted ways with Hero way back in 2010-11, Honda has been going flat out to increase capacity across its plants. The Indian arm, HMSI (Honda Motorcycle & Scooter India) started operations at a single plant in Manesar, Haryana, but over the years has expanded its presence to Rajasthan, Karnataka and Gujarat. Its total capacity is over six million units and could well cross the seven million mark in the next couple of years. Yet, the larger objective of not being able to get past Hero has been a constant source of angst for HMSI even while its leadership team has proclaimed on more than one occasion that it is only a matter of time before this is done. Perhaps, the company underestimated the strengths of Hero when it came to its huge retail network along with the twin jewels in its kitty — Splendor and Passion — which have kept its sales charts afire for many years now. Activa vs Splendor It is to HMSI's credit though that it has emerged the second largest player in India now and has even gone ahead of Hero in some months when its Activa scooter triumphed over Splendor. Other rivals like Bajaj Auto and TVS Motor have attempted in the past to overtake Hero but the might of Splendor was a little to difficult to take head-on. There were serious attempts made by Bajaj to reboot its Discover motorcycle in different avatars but Splendor eventually prevailed and it was finally a scooter, Honda Activa, which ended up being its closest rival and even taking the top spot on some occasions. The Splendor has a long history which has been appreciated by people in India. The product still remains Kawaguchi Following the split with Hero, a senior Honda official had told this writer that dislodging a brand like Splendor was not the main objective or scope of Honda's business in India. 'The more we sell in the current market, the more we will take customers from competitors. As a result, some OEM brand may see a reduction in market share or volumes. While respecting all competitors, we should create a healthy industry and market especially from the viewpoint of road safety,' he said. He was also quick to acknowledge that many Indian buyers 'think highly' of a reliable product or brand. 'The Splendor has a long history which has been appreciated by people in India. The product still remains good,' said the Honda senior official. Drawing more customers According to him, the sales performance of the Activa was 'far better' than Honda's expectations. 'Additional supply also helps create more and more customers. Today even in rural areas, the scooter segment boasts of high sales. This naturally accelerates demand for our scooter range,' he explained. Honda, continued the official, was still busy expanding capacity to meet the growing demand for scooters. 'I agree that the image of the brand is stronger in scooters than motorcycles. However, this will change over a longer time period,' he said. Also read:Honda targets two-wheeler leadership in India this fiscal It was also the official's view that motorcycles would remain the top preference for Indian customers. 'However, this situation may change after a decade. Year after year, the scooter is becoming more important in the market since it offers greater versatility when it comes to usage,' he elaborated. Since the time of this interview which happened some years ago, the two-wheeler terrain in India has changed quite a bit with electric now being an integral presence. It is here that legacy players like TVS Motor and Bajaj Auto are leading the race along with Ather and Ola following behind. Different ballgame with electric Hero has not replicated the success it has had in the ICE (internal combustion engine) space while Honda has been a late entrant and not quite made any sizable impact yet with its Activa-e: and QC 1 electric scooters. In the ICE arena, of course, it is firing on all cylinders and keen on overtaking Hero this fiscal. During the course of a press meet in Japan earlier this year, Honda officials had said the company would strive to become the leading player in India's electric two-wheeler market. It said it would sell its electric models in the price range where the cost of ownership for three years would be equivalent to that of ICE models. Also read:For honda, its time has 'finally come' to race past hero 'To achieve this target, Honda will begin operating a dedicated electric motorcycle production plant in India in 2028. A wide variety of electric models will be produced by combining modules that are common for multiple models. Additionally, for batteries, Honda has been working with manufacturers to establish specifications suited to the characteristics of two-wheeler and ensure stable procurement,' said the company representatives. Specifically on India, Honda said it would pursue various initiatives to strengthen its business including the automation of production plants and active cultivation and utilisation of local suppliers. In addition, it planned to implement efficient product strategies globally, such as exporting high-value, highly-competitive products nurtured in India to the South American market where customer needs are similar. India as global hub 'Honda is expecting to see a further increase of motorcycle demand also in ASEAN countries, Pakistan, Bangladesh and Brazil due to an increase in the working population that overlaps with the motorcycle user population. Seizing this opportunity, Honda will further solidify its motorcycle business by fully leveraging its strengths in products as well as sales, service, procurement and production operations on a global basis,' said its leadership team at the meeting in Japan. Interestingly, neither TVS Motor nor Bajaj Auto seems as obsessed any longer with the leadership stakes in India which has pretty much boiled down to a tug-of-war between Hero and Honda. Bajaj, over the years, has been paying more attention to its global ambitions where partnerships with KTM and Triumph are playing a key role in exploring new geographies. In addition, its own motorcycles and three-wheelers are being shipped out worldwide. TVS Motor, likewise, has been on a global trail with brands like BMW Motorrad and Norton fuelling the cause. It also has successful homegrown brands like Jupiter and Apache which are also doing well in India and other countries. TVS has also been among the first to pick up the electric vehicle gauntlet where it is the leading player this fiscal.
